Patent US4871718A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4871718A Expired / Lapsed US ⏱️ 0.0 years remaining

Composition of matter for increasing intracellular ATP levels and physical performance levels and for increasing the rate of wound repair

Assignee: RONCARI RAYMOND A 168 ELM STREET WINDSOR LOCKS CONNECTICUT 06096
•
Filing: 1987-12-29
•
Granted: 1989-10-03
•
Expires: 2007-12-29
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A composition of matter for increasing the intracellular synthesis of ATP. The composition consists of amino acids, metabolites, electrolyte and a pentose sugar. When applied to wounds, the invention increases the rate of wound repair. When administered orally, the invention increases ATP blood levels and physical performance levels.

Inventors

  • 👤 Francis J. Carniglia

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-01 16:57
CPC Classifications
A; A61; A61K; A61K38/00; A61K38/01; A61P; A61P17/00; A61P3/00; A61P3/12; A61P43/00

Claims Analysis

Total Claims: 22
Claim 1
Independent Claim 45 words
A composition of matter for increasing the intracellular level of ATP comprising: amino acids selected from the group of amino acids which are the metabolic precursors of ATP; at least one metabolite selected from the group consisting of choline chloride and inositol; electrolyte; and ribose.
Claim 2
Dependent Claim 45 words
A composition of matter for increasing the intracellular level of ATP comprising: amino acids selected from the group of amino acids which are the metabolic precursors of ATP; at least one metabolite selected from the group consisting of choline chloride and inositol; electrolyte; and ribose.
Claim 3
Dependent Claim 22 words
The composition of claim 1 wherein the amino acids consist of L-glycine, L-arginine, D/L methionine, L-aspartic acid, L-tryptophan, L-pheylalanine, L-histidine and L-proline.
Claim 4
Dependent Claim 14 words
The composition of claim 1 wherein the metabolites consist of choline chloride and inositol.
Claim 5
Dependent Claim 12 words
The composition of claim 1 wherein the electrolyte consists of magnesium phosphate.
Claim 6
Dependent Claim 38 words
The composition of claim 1 consisting of by weight percentage: L-glycine (0.80-98%), L-arginine (3.19-3.89%), D/L-methionine (15.95-19.49%), choline chloride (13.43-16.41%), inositol (11.83-14.47%), L-aspartic acid (11.83-14.47%), L-tryptophan (3.46-4.22%), L-pheylalanine (2.79-3.41%), L-histidine (2.65-3.24%), L-proline (2.00-2.44%), D-ribose (11.84-14.47%) and magnesium phosphate (10.23-12.51%).
Claim 7
Dependent Claim 45 words
A composition of matter for increasing the intracellular synthesis of ATP consisting of by weight percentage: L-glycine (0.89%), L-arginine (3.54%), D/L methionine (17.72%), choline chloride (14.92%), inositol (13.15%), L-aspartic acid (13.15%), L-tryptophan (3.84%), L-pheylalanine (3.10%), L-histidine (2.95%), L-proline (2.22%), D-ribose (13.15%) and magnesium phosphate (11.37%).
Claim 8
Dependent Claim 45 words
A composition of matter for increasing the intracellular synthesis of ATP consisting of by weight percentage: L-glycine (0.89%), L-arginine (3.54%), D/L methionine (17.72%), choline chloride (14.92%), inositol (13.15%), L-aspartic acid (13.15%), L-tryptophan (3.84%), L-pheylalanine (3.10%), L-histidine (2.95%), L-proline (2.22%), D-ribose (13.15%) and magnesium phosphate (11.37%).
Claim 9
Dependent Claim 53 words
A mixture for increasing the intracellular level of ATP and physical performance levels in horses comprising: amino acids selected from the group of amino acids which are the metabolitic precursors of ATP; at least one metabolite selected from the group consisting of choline chloride and inositol; electrolyte, ribose, vitamins, minerals and flavoring agents.
Claim 10
Dependent Claim 53 words
A mixture for increasing the intracellular level of ATP and physical performance levels in horses comprising: amino acids selected from the group of amino acids which are the metabolitic precursors of ATP; at least one metabolite selected from the group consisting of choline chloride and inositol; electrolyte, ribose, vitamins, minerals and flavoring agents.
Claim 11
Dependent Claim 22 words
The mixture of claim 7 wherein the amino acids consist of L-glycine, L-arginine, D/L methionine, L-aspartic acid, L-tryptophan, L-pheylalanine, L-histidine and L-proline.
Claim 12
Dependent Claim 14 words
The mixture of claim 7 wherein the metabolites consist of choline chloride and inositol.
Claim 13
Dependent Claim 12 words
The mixture of claim 7 wherein the electrolyte consist of magnesium phosphate.
Claim 14
Dependent Claim 106 words
The mixture of claim 7 consisting of by weight; L-glycine (0.6 Kg), L-arginine (2.4 Kg), D/L methionine (12.0 Kg), choline chloride (10.1 Kg), inositol (8.9 Kg), L-aspartic acid (8.9 Kg), L-tryptophan (2.6 Kg), L-pheylalanine (2.1 Kg), L-histidine (2.0 Kg), L-proline (1.5 Kg), ribose (8.9 Kg), magnesium phosphate (7.7 Kg), lactalbumin (300 Kg), Saccharomyces cerevisiae culture (340.9 Kg), dried beet molasses (181.8 Kg), dicalcium phosphate (90.9 Kg), sodium bicarbonate (22.7 Kg), a multi-vitamin mixture comprising vitamin A, vitamin D3, vitamin E, vitamin B12, riboflavin, niacin, pantothenic acid, menadione, folic acid, thiamine, pyridoxine, ascorbic acid and biotin (45.45 Kg), lignan sulphate (13.07 Kg) and flavoring agents (1.36 Kg).
Claim 15
Dependent Claim 44 words
A pharmaceutical preparation for increasing the rate of wound repair consisting of by weight percentage: L-glycine (0.80-0.98%), L-arginine (3.19-3.89%), D/L methionine (15.95-19.49%), choline chloride (13.43-16.41%), inositol (11.83-14.47%), L-aspartic acid (11.83-14.47%), L-tryptophan (3.46-4.22%), L-pheylalanine (2.79-3.41%), L-histidine (2.65-3.24%), L-proline (2.0-2.44%), D-ribose (11.84-14.47%) and magnesium phosphate (10.23-12.51%).
Claim 16
Dependent Claim 44 words
A pharmaceutical preparation for increasing the rate of wound repair consisting of by weight percentage: L-glycine (0.80-0.98%), L-arginine (3.19-3.89%), D/L methionine (15.95-19.49%), choline chloride (13.43-16.41%), inositol (11.83-14.47%), L-aspartic acid (11.83-14.47%), L-tryptophan (3.46-4.22%), L-pheylalanine (2.79-3.41%), L-histidine (2.65-3.24%), L-proline (2.0-2.44%), D-ribose (11.84-14.47%) and magnesium phosphate (10.23-12.51%).
Claim 17
Dependent Claim 44 words
A pharmaceutical preparation for increasing the rate of wound repair consisting of by weight percentage: L-glycine (0.89%), L-arginine (3.54%), D/L methionine (17.72%), choline chloride (14.92%), inositol (13.15%), L-aspartic acid (13.15%), L-tryptophan (3.84%), L-pheylalanine (3.1%), L-histidine (2.95%), L-proline (2.22%), D-ribose (13.15%) and magnesium phosphate (11.37%).
Claim 18
Dependent Claim 44 words
A pharmaceutical preparation for increasing the rate of wound repair consisting of by weight percentage: L-glycine (0.89%), L-arginine (3.54%), D/L methionine (17.72%), choline chloride (14.92%), inositol (13.15%), L-aspartic acid (13.15%), L-tryptophan (3.84%), L-pheylalanine (3.1%), L-histidine (2.95%), L-proline (2.22%), D-ribose (13.15%) and magnesium phosphate (11.37%).
Claim 19
Dependent Claim 13 words
The preparation of claim 13 wherein the preparation is solubilized in normal saline.
Claim 20
Dependent Claim 18 words
The preparation of claim 13 wherein the preparation is solubilized in normal saline at a 1% w/v concentration.
Claim 21
Dependent Claim 13 words
The preparation of claim 13 wherein the preparation is incorporated into a gel.
Claim 22
Dependent Claim 18 words
The preparation of claim 13 wherein the prepartion is incorporated into the gel at a 1% w/v concentration.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1992-10-02 1993-04-03 1993-10-03 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1996-10-02 1997-04-03 1997-10-03 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2000-10-02 2001-04-03 2001-10-03 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag